Shashi Amur

4.4k total citations
25 papers, 999 citations indexed

About

Shashi Amur is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Hepatology. According to data from OpenAlex, Shashi Amur has authored 25 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Hepatology. Recurrent topics in Shashi Amur's work include Hepatitis C virus research (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Shashi Amur is often cited by papers focused on Hepatitis C virus research (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Shashi Amur collaborates with scholars based in United States, Australia and Canada. Shashi Amur's co-authors include Padmaja Mummaneni, Felix W. Frueh, Lawrence J. Lesko, Ameeta Parekh, Gilbert J. Burckart, Issam Zineh, Janet Woodcock, Robert R. Verbrugge, Robert S. Epstein and Ronald E. Aubert and has published in prestigious journals such as Hepatology, American Journal of Respiratory and Critical Care Medicine and Neuropsychopharmacology.

In The Last Decade

Shashi Amur

25 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shashi Amur United States 17 221 189 179 106 100 25 999
Pär Hallberg Sweden 18 137 0.6× 192 1.0× 74 0.4× 148 1.4× 104 1.0× 62 1.1k
Christian M. Shaffer United States 22 457 2.1× 102 0.5× 154 0.9× 79 0.7× 60 0.6× 52 1.4k
Rebecca L. Roberts New Zealand 18 203 0.9× 145 0.8× 196 1.1× 74 0.7× 117 1.2× 26 945
Pallav Bhatnagar United States 14 207 0.9× 453 2.4× 102 0.6× 178 1.7× 135 1.4× 28 1.2k
Philippe Jacqmin Belgium 20 253 1.1× 59 0.3× 413 2.3× 242 2.3× 195 1.9× 57 1.5k
Wei Wei Liu China 25 447 2.0× 221 1.2× 88 0.5× 234 2.2× 104 1.0× 80 1.7k
Elizabeta Topić Croatia 17 190 0.9× 81 0.4× 72 0.4× 64 0.6× 50 0.5× 69 936
Gurdeep S. Sagoo United Kingdom 19 466 2.1× 84 0.4× 163 0.9× 89 0.8× 227 2.3× 46 1.4k
Nathalie Gérard France 21 304 1.4× 337 1.8× 221 1.2× 219 2.1× 112 1.1× 58 1.3k
Manoranjenni Chetty United Kingdom 18 221 1.0× 217 1.1× 109 0.6× 205 1.9× 179 1.8× 41 953

Countries citing papers authored by Shashi Amur

Since Specialization
Citations

This map shows the geographic impact of Shashi Amur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashi Amur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashi Amur more than expected).

Fields of papers citing papers by Shashi Amur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashi Amur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashi Amur. The network helps show where Shashi Amur may publish in the future.

Co-authorship network of co-authors of Shashi Amur

This figure shows the co-authorship network connecting the top 25 collaborators of Shashi Amur. A scholar is included among the top collaborators of Shashi Amur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashi Amur. Shashi Amur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Troth, Sean P., Kateřina Vlasáková, Shashi Amur, Rupesh P. Amin, & Warren E. Glaab. (2019). Translational Safety Biomarkers of Kidney Injury. Seminars in Nephrology. 39(2). 202–214. 7 indexed citations
2.
Wu, Ann Chen, James P. Kiley, Patricia J. Noel, et al.. (2018). Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement. American Journal of Respiratory and Critical Care Medicine. 198(12). e116–e136. 38 indexed citations
3.
Hesterlee, Sharon, Shashi Amur, Lisa J. Bain, et al.. (2017). Patient-Centered Therapy Development for Myotonic Dystrophy: Report of the Myotonic Dystrophy Foundation–Sponsored Workshop. Therapeutic Innovation & Regulatory Science. 51(4). 516–522. 2 indexed citations
4.
Amur, Shashi, et al.. (2015). Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization. Clinical Pharmacology & Therapeutics. 98(1). 34–46. 132 indexed citations
5.
Bough, Kristopher J., Shashi Amur, Scott E. Hemby, et al.. (2013). Biomarkers for the Development of New Medications for Cocaine Dependence. Neuropsychopharmacology. 39(1). 202–219. 28 indexed citations
6.
Bough, Kristopher J., Caryn Lerman, Jed E. Rose, et al.. (2013). Biomarkers for Smoking Cessation. Clinical Pharmacology & Therapeutics. 93(6). 526–538. 43 indexed citations
7.
Florian, Jeffry, Pravin Jadhav, Shashi Amur, et al.. (2012). Boceprevir dosing for late responders and null responders: The role of bridging data between treatment-naïve and -experienced subjects. Hepatology. 57(3). 903–907. 9 indexed citations
8.
Liu, Jiang, Pravin Jadhav, Shashi Amur, et al.. (2012). Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects. Hepatology. 57(3). 897–902. 9 indexed citations
9.
Amur, Shashi, Ameeta Parekh, & Padmaja Mummaneni. (2011). Sex differences and genomics in autoimmune diseases. Journal of Autoimmunity. 38(2-3). J254–J265. 94 indexed citations
10.
Haas, David W., Daniel R. Kuritzkes, Marylyn D. Ritchie, et al.. (2011). Pharmacogenomics of HIV Therapy: Summary of a Workshop Sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials. 12(5). 277–285. 10 indexed citations
11.
Arasappan, Dhivya, Weida Tong, Padmaja Mummaneni, Hong Fang, & Shashi Amur. (2011). Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Medicine. 9(1). 65–65. 50 indexed citations
12.
Zineh, Issam, et al.. (2011). Allopurinol Pharmacogenetics: Assessment of Potential Clinical Usefulness. Pharmacogenomics. 12(12). 1741–1749. 28 indexed citations
13.
Tesch, Greg H., Shashi Amur, John T. Schousboe, et al.. (2010). Successes Achieved and Challenges Ahead in Translating Biomarkers into Clinical Applications. The AAPS Journal. 12(3). 243–253. 17 indexed citations
14.
Burckart, Gilbert J. & Shashi Amur. (2010). Update on the Clinical Pharmacogenomics of Organ Transplantation. Pharmacogenomics. 11(2). 227–236. 14 indexed citations
15.
Frueh, Felix W., Shashi Amur, Padmaja Mummaneni, et al.. (2008). Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(8). 992–998. 208 indexed citations
16.
Amur, Shashi, Felix W. Frueh, Lawrence J. Lesko, & Shiew‐Mei Huang. (2008). Integration and Use of Biomarkers in Drug Development, Regulation and Clinical Practice: a US Regulatory Perspective. Biomarkers in Medicine. 2(3). 305–311. 70 indexed citations
17.
Burckart, Gilbert J., Shashi Amur, Federico Goodsaid, et al.. (2008). Qualification of Biomarkers for Drug Development in Organ Transplantation. American Journal of Transplantation. 8(2). 267–270. 21 indexed citations
18.
Orr, Michael S., et al.. (2007). The Experience with Voluntary Genomic Data Submissions at the FDA and a Vision for the Future of the Voluntary Data Submission Program. Clinical Pharmacology & Therapeutics. 81(2). 294–297. 22 indexed citations
19.
Lacaná, Emanuela, et al.. (2007). The Emerging Role of Pharmacogenomics in Biologics. Clinical Pharmacology & Therapeutics. 82(4). 466–471. 28 indexed citations
20.
Hoffmann, Steven C., Robert L. Kampen, Shashi Amur, et al.. (2002). Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation. 74(7). 916–923. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pär Hallberg Breakdown of academic impact, for papers by Christian M. Shaffer Breakdown of academic impact, for papers by Rebecca L. Roberts Breakdown of academic impact, for papers by Pallav Bhatnagar Breakdown of academic impact, for papers by Philippe Jacqmin Breakdown of academic impact, for papers by Wei Wei Liu Breakdown of academic impact, for papers by Elizabeta Topić Breakdown of academic impact, for papers by Gurdeep S. Sagoo Breakdown of academic impact, for papers by Nathalie Gérard Breakdown of academic impact, for papers by Manoranjenni Chetty
Rankless by CCL
2026